South Korea Counts Five Drug Makers Set To Produce Flu Vaccines
This article was originally published in PharmAsia News
Executive SummarySeveral South Korean drug makers are working to become major players in the nation's flu vaccine market in the wake of the recent pandemic scare
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.